Control selection strategies, such as comparing cases to controls that have been selected on the basis of their PSA level being under a certain threshold, can make it difficult to interpret associations between a genetic variant and disease, since such associations may result from a relationship between the variant and PSA levels rather than prostate cancer [20,29–36]. The gene discussed is KLK3; the disease is Familial prostate cancer.